Endophthalmitis most often caused by Staphylococcus

Article

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it. That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA.

Endophthalmitis is most often caused by coagulase-negative Staphylococcus, and the antibiotics vancomycin and ceftazidime seem to perform well in treating it.

That was one of the findings of a 25-year retrospective study conducted by Dr Ronald C. Gentile, of the New York Eye and Ear Infirmary, and his colleagues in New York City and San Antonio, Texas, USA. The researchers set out to look for trends related to pathogens and antibiotics over the past 25 years. They reported their results in Ophthalmology.

Other findings:

  • Many antibiotics, among them cephalosporins and methicillin, are associated with a statistically significant trend in increasing microbial resistance.
  • A significant trend toward decreasing microbial resistance against aminoglycosides and imipenem also exists.

The researchers studied 911 eyes with a total of 988 consecutive culture-positive endophthalmitis isolates that had been collected from 1987 to 2011. The pathogens they most frequently found were coagulase-negative Staphylococcus (39.4%), Streptococcus viridans species (12.1%) and Staphylococcus aureus (11.1%). Gram-negative organisms accounted for 10.3% of all isolates and fungi accounted for 4.6% of them.

Two isolates, Enterococcus faecium and Nocardia exalbida, were not susceptible to vancomycin, but the rest of the 725 gram-positive bacteria they tested were susceptible. The researchers tested 94 gram-negative organisms against ceftazidime and found that 2 were of intermediate sensitivity and 6 were resistant.

The researchers found that microbial resistance was associated with 8 antibiotics as time went on. Those 8 were ampicillin, cefazolin, cefotetan, ceftriaxone, cephalothin, clindamycin, erythromycin and methicillin/oxacillin. They saw increasing microbial susceptibility with 3 antibiotics: gentamicin, imipenem and tobramycin.

To read the abstract of the study click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.